Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

ETOPOSIDE-TEVA INJECTION 20 mg/ml

Approval Number

SIN10059P

Drug Name

ETOPOSIDE-TEVA INJECTION 20 mg/ml

Product Name

ETOPOSIDE-TEVA INJECTION 20 mg/ml

Approval Date

September 29, 1998

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

L01CB01

ATC Item Name

etoposide

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

PHARMACHEMIE BV

Active Ingredients

Ingredient Name

ETOPOSIDE

Strength

20 mg/ml

Drug MonographEtoposide

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

ETOPOSIDE-TEVA INJECTION 20 mg/ml - HSA Approval | MedPath